CN105907861A - Method and primer for quick detection and classification of mycobacteria - Google Patents
Method and primer for quick detection and classification of mycobacteria Download PDFInfo
- Publication number
- CN105907861A CN105907861A CN201610292154.1A CN201610292154A CN105907861A CN 105907861 A CN105907861 A CN 105907861A CN 201610292154 A CN201610292154 A CN 201610292154A CN 105907861 A CN105907861 A CN 105907861A
- Authority
- CN
- China
- Prior art keywords
- primer
- mycobacterium
- pcr amplification
- mycobacteria
- fragment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000001514 detection method Methods 0.000 title claims abstract description 37
- 238000000034 method Methods 0.000 title claims abstract description 29
- 238000012408 PCR amplification Methods 0.000 claims description 132
- 241000186359 Mycobacterium Species 0.000 claims description 53
- 230000001580 bacterial effect Effects 0.000 claims description 14
- 241000187479 Mycobacterium tuberculosis Species 0.000 claims description 12
- 241000187919 Mycobacterium microti Species 0.000 claims description 10
- 238000007400 DNA extraction Methods 0.000 claims description 6
- 241000186366 Mycobacterium bovis Species 0.000 claims description 6
- 238000000246 agarose gel electrophoresis Methods 0.000 claims description 5
- 238000006243 chemical reaction Methods 0.000 claims description 5
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 claims description 4
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 claims description 2
- 108010067770 Endopeptidase K Proteins 0.000 claims description 2
- 238000011144 upstream manufacturing Methods 0.000 claims description 2
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 claims 1
- 238000002360 preparation method Methods 0.000 claims 1
- 201000008827 tuberculosis Diseases 0.000 abstract description 26
- 241001302239 Mycobacterium tuberculosis complex Species 0.000 abstract description 20
- 238000002512 chemotherapy Methods 0.000 abstract description 4
- 238000003759 clinical diagnosis Methods 0.000 abstract description 4
- 230000000813 microbial effect Effects 0.000 abstract description 2
- 239000012634 fragment Substances 0.000 description 117
- 230000003321 amplification Effects 0.000 description 27
- 238000003199 nucleic acid amplification method Methods 0.000 description 27
- 241001467553 Mycobacterium africanum Species 0.000 description 9
- 241000211133 Mycobacterium caprae Species 0.000 description 5
- 241001467552 Mycobacterium bovis BCG Species 0.000 description 4
- 241001312372 Mycobacterium canettii Species 0.000 description 4
- 241000186365 Mycobacterium fortuitum Species 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 239000011541 reaction mixture Substances 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- LXAHHHIGZXPRKQ-UHFFFAOYSA-N 5-fluoro-2-methylpyridine Chemical compound CC1=CC=C(F)C=N1 LXAHHHIGZXPRKQ-UHFFFAOYSA-N 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 230000004544 DNA amplification Effects 0.000 description 1
- 208000031998 Mycobacterium Infections Diseases 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 238000001502 gel electrophoresis Methods 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 208000027531 mycobacterial infectious disease Diseases 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 238000007894 restriction fragment length polymorphism technique Methods 0.000 description 1
- 125000006850 spacer group Chemical group 0.000 description 1
- 241000894007 species Species 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
- C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/686—Polymerase chain reaction [PCR]
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
本发明属于微生物分子检测领域,尤其涉及一种用于分枝杆菌快速检测与分型的引物及方法。本发明提供的用于分枝杆菌快速检测与分型的引物,包括7对分枝杆菌的特异性引物。本发明提供的用于分枝杆菌快速检测与分型的引物不仅可以区分结核分枝杆菌和非结核分枝杆菌,还可以进一步的区分结核分枝杆菌复合群中的各成员菌,具有特异性好、准确性高的优点,可以有效的辅助结核病的临床诊断、指导临床开展早期有效的化疗。
The invention belongs to the field of microbial molecular detection, in particular to a primer and a method for rapid detection and typing of mycobacteria. The primers for rapid detection and typing of mycobacteria provided by the invention include 7 pairs of specific primers for mycobacteria. The primers provided by the present invention for the rapid detection and typing of mycobacteria can not only distinguish tuberculosis mycobacteria and non-tuberculous mycobacteria, but also can further distinguish each member of the tuberculosis mycobacterium complex, with specificity With the advantages of high precision and high accuracy, it can effectively assist the clinical diagnosis of tuberculosis and guide the clinical development of early and effective chemotherapy.
Description
技术领域technical field
本发明属于微生物分子检测领域,尤其涉及一种用于分枝杆菌快速检测与分型的引物及方法。The invention belongs to the field of microbial molecular detection, in particular to a primer and a method for rapid detection and typing of mycobacteria.
背景技术Background technique
目前,结核病仍然是严重的公共卫生问题,其在全世界范围内出现不断上升的趋势。结核分枝杆菌复合群(Mycobacterium tuberculosis complex,MTC)是引起人类结核病的主要病原菌。MTC包括结核分枝杆菌(M.Tuberculosis)、非洲分枝杆菌(I型和II型)(M.AfricanumI型和II型)、牛分枝杆菌(M.Bovis)、卡介苗(M.bovis BCG)、田鼠分枝杆菌(M.Microti)、山羊分枝杆菌(M.Caprae)以及肯尼迪分枝杆菌(M.Canettii)。At present, tuberculosis is still a serious public health problem, and it is on the rise all over the world. Mycobacterium tuberculosis complex (MTC) is the main pathogenic bacteria causing human tuberculosis. MTC includes Mycobacterium tuberculosis (M.Tuberculosis), Mycobacterium Africa (Type I and Type II) (M.Africanum Type I and Type II), Mycobacterium bovis (M.Bovis), BCG (M.bovis BCG) , Mycobacterium microti (M. Microti), Mycobacterium caprae (M. Caprae) and Mycobacterium Kennedy (M. Canettii).
在检测分枝杆菌时,非结核分枝杆菌(MOTT)与结核分枝杆菌很难区分,但是结核分枝杆菌与非结核分枝杆菌在治疗上存在极大的差异,若对结核病患者盲目的用药,容易导致耐药菌株的产生,加重病情。因此,在临床上建立一种快速、准确的检测结核与非结核分枝杆菌菌种,同时还能进一步区分鉴定结核分枝杆菌复合群中各成员菌的方法,是有效治疗或控制结核病的重要提前。In the detection of mycobacteria, it is difficult to distinguish non-tuberculous mycobacteria (MOTT) from mycobacterium tuberculosis, but there are great differences in treatment between mycobacterium tuberculosis and non-tuberculosis mycobacteria. Medication can easily lead to the emergence of drug-resistant strains and aggravate the condition. Therefore, it is important to effectively treat or control tuberculosis to establish a rapid and accurate method for detecting tuberculosis and non-tuberculosis mycobacteria strains clinically, and to further distinguish and identify the members of the Mycobacterium tuberculosis complex. in advance.
目前,检测分枝杆菌的方法主要有:限制性片段长度多态性分析(IS6110-RFLP)、间隔寡核苷酸分型技术(Spoligotyping)、可变数目的串联重复序列(MIRU)、以及可变数目串联重复序列分型方法(VNTR)。IS6110-RFLP具有较高的分辨率和较好的重复性,但对于携带1个或较少的IS6110拷贝数的菌株来说其鉴别能力较低;另外在一些非结核分枝杆菌菌株中也发现有IS6110拷贝。Spoligotyping不需要大量DNA,可对分枝杆菌进一步分型到亚种水平,但其分辨率低,成本较高,检测效率与预期尚有差距。MIRU也不需要大量高质量的DNA,试验结果可以进行数字化编码,便于各个实验室之间结果的比较,VNTR分型重复性、敏感性、特异性均为100%,但与MIRU和VNTR不同位点的多态性决定了该方法的分辨率,限制了上述两种方法的使用。At present, the methods for detecting mycobacteria mainly include: restriction fragment length polymorphism analysis (IS6110-RFLP), spacer oligonucleotide typing technique (Spoligotyping), variable number of tandem repeats (MIRU), and variable number of tandem repeats (MIRU). Number of tandem repeats typing method (VNTR). IS6110-RFLP has high resolution and good reproducibility, but its discrimination ability is low for strains carrying 1 or less copies of IS6110; it is also found in some non-tuberculous mycobacteria strains There is a copy of IS6110. Spoligotyping does not require a large amount of DNA, and can further type mycobacteria to the subspecies level, but its resolution is low, the cost is high, and the detection efficiency is still far behind expectations. MIRU does not require a large amount of high-quality DNA, and the test results can be digitally coded to facilitate the comparison of results between laboratories. The repeatability, sensitivity, and specificity of VNTR typing are 100%, but they are different from MIRU and VNTR. The polymorphism of points determines the resolution of the method, limiting the use of the above two methods.
为了解决上述问题,越来越多的分枝杆菌检测方法应运而生。中国专利CN102304575B公开了一种快速鉴定结核分枝杆菌与非结核分枝杆菌的方法,具体涉及一种用环介导等温基因扩增技术(LAMP技术),其原理是根据结核分枝杆菌与非结核分枝杆菌16SRNA的特异性设计4条特异性引物,进行PCR扩增,通过SYBRGreenI观察颜色变化来判断结果。该鉴定方法具有方便快捷,灵敏度高,特异性高等优点,对于结核分枝杆菌或非结核分枝杆菌感染的诊断与临床用药具有较高的参考价值,适于推广应用。但是该鉴定方法只能区分结核分枝杆菌与非结核分枝杆菌,不能进一步对结核分枝杆菌进行分型,不利于该鉴定方法的推广和应用。In order to solve the above problems, more and more detection methods for mycobacteria have emerged as the times require. Chinese patent CN102304575B discloses a method for rapid identification of Mycobacterium tuberculosis and non-tuberculous mycobacteria, and specifically relates to a loop-mediated isothermal gene amplification technology (LAMP technology). The specificity of Mycobacterium tuberculosis 16SRNA Design 4 specific primers, perform PCR amplification, and judge the result by observing the color change with SYBRGreenI. The identification method has the advantages of convenience, high sensitivity, high specificity, etc., has high reference value for the diagnosis and clinical application of mycobacterium tuberculosis or non-tuberculosis mycobacterium infection, and is suitable for popularization and application. However, this identification method can only distinguish tuberculosis mycobacteria from non-tuberculosis mycobacteria, and cannot further type mycobacterium tuberculosis, which is not conducive to the promotion and application of this identification method.
发明内容Contents of the invention
为了解决现有技术中分枝杆菌检测方法存在的检测范围窄、特异性不强的缺陷,本发明的目的在于提供一种用于分枝杆菌快速检测与分型的引物及方法,以解决上述问题。In order to solve the defects of narrow detection range and low specificity in the mycobacteria detection method in the prior art, the purpose of the present invention is to provide a kind of primer and method for rapid detection and typing of mycobacteria to solve the above-mentioned problems. question.
本发明提供了一种用于分枝杆菌快速检测与分型的引物,包括以下7对分枝杆菌特异性引物:The present invention provides a primer for rapid detection and typing of mycobacteria, including the following 7 pairs of mycobacterium-specific primers:
MycoF1:5’-GGCAAGGTCACCCCGAAGGG-3’(SEQ ID NO.1),MycoF1: 5'-GGCAAGGTCACCCCCGAAGGG-3' (SEQ ID NO.1),
MycoR1:5’-AGCGGCTGCTGGGTGATCATC-3’(SEQ ID NO.2);MycoR1: 5'-AGCGGCTGCTGGGTGATCATC-3' (SEQ ID NO.2);
MycoF2:5’-TCGCGTGATCCTTCGAAACG-3’(SEQ ID NO.3),MycoF2: 5'-TCGCGTGATCCTTCGAAACG-3' (SEQ ID NO.3),
MycoR2:5’-GCCGTTGCGCTGATTGGACC-3’(SEQ ID NO.4);MycoR2: 5'-GCCGTTGCGCTGATTGGACC-3' (SEQ ID NO.4);
MycoF3:5’-GACCTGACGCCGCTGACAC-3’(SEQ ID NO.5),MycoF3: 5'-GACCTGACGCCGCTGACAC-3' (SEQ ID NO.5),
MycoR3:5’-CACCTACACCGCTTCCTGCC-3’(SEQ ID NO.6);MycoR3: 5'-CACCTACACCGCTTCCTGCC-3' (SEQ ID NO.6);
MycoF4:5’-GACATGTACGAGAGACGGCATGAG-3’(SEQ ID NO.7),MycoF4: 5'-GACATGTACGAGAGACGGCATGAG-3' (SEQ ID NO.7),
MycoR4:5’-AATCCAACACGCAGCAACCAG-3’(SEQ ID NO.8);MycoR4: 5'-AATCCAACACGCAGCAACCAG-3' (SEQ ID NO.8);
MycoF5:5’-AGGGATTCGGCGTTCGGGATTCCTG-3’(SEQ ID NO.9),MycoF5: 5'-AGGGATTCGGCGTTCGGGATTCCTG-3' (SEQ ID NO.9),
MycoR5:5’-GATCGCGATCGCCAACGATTCAGTGTATG-3’(SEQ ID NO.10);MycoR5: 5'-GATCGCGATCGCCAACGATTCAGTGTATG-3' (SEQ ID NO.10);
MycoF6:5’-GGGTCTGACGGCCAAACTC-3’(SEQ ID NO.11),MycoF6: 5'-GGGTCTGACGGCCAAACTC-3' (SEQ ID NO.11),
MycoR6:5’-CTCGGTGGCCGGTTTTTC-3’(SEQ ID NO.12);MycoR6: 5'-CTCGGTGGCCGGTTTTTC-3' (SEQ ID NO.12);
MycoF7:5’-CGATAGACCATGAGTCCGTCTC-3’(SEQ ID NO.13),MycoF7: 5'-CGATAGACCATGAGTCCGTCTC-3' (SEQ ID NO.13),
MycoR7:5’-GTGGGCGGATGCCAGAATAG-3’(SEQ ID NO.14)。MycoR7: 5'-GTGGGCGGATGCCAGAATAG-3' (SEQ ID NO. 14).
进一步地,所述分枝杆菌特异引物的上游引物与下游引物的浓度比为1∶1。Further, the concentration ratio of the upstream primer to the downstream primer of the mycobacterium-specific primer is 1:1.
另外,本发明还提供了一种用于分枝杆菌快速检测与分型的方法,包括如下步骤:In addition, the present invention also provides a method for rapid detection and typing of mycobacteria, comprising the following steps:
S1应用细菌基因组DNA提取液提取待测标本中的细菌基因组DNA;S1 Use the bacterial genomic DNA extraction solution to extract the bacterial genomic DNA in the specimen to be tested;
S2以待测标本中的细菌基因组DNA为模板,采用权利要求1所述的7对分枝杆菌特异引物分别进行PCR扩增;S2 uses the bacterial genome DNA in the sample to be tested as a template, and uses 7 pairs of mycobacterium-specific primers according to claim 1 to carry out PCR amplification respectively;
S3将所得的PCR产物进行琼脂糖凝胶电泳。S3 The obtained PCR product is subjected to agarose gel electrophoresis.
进一步地,所述步骤S1中细菌基因组DNA提取液的配方为:Chelex 100 resin 5%;Tris-HCl 10mM,pH8.3;乙二胺四乙酸二钠0.1mM;叠氮钠0.1%;蛋白酶K 100μg/ml。Further, the formula of bacterial genomic DNA extract in the step S1 is: Chelex 100 resin 5%; Tris-HCl 10mM, pH8.3; EDTA disodium 0.1mM; sodium azide 0.1%; proteinase K 100 μg/ml.
进一步地,所述步骤S2中的PCR扩增反应条件包括:阶段1:95℃5min;阶段2:95℃1min;阶段3:58℃1min;阶段4:72℃1min;32个循环;阶段5:72℃5min;在16℃贮存。Further, the PCR amplification reaction conditions in the step S2 include: stage 1: 95°C for 5 minutes; stage 2: 95°C for 1 minute; stage 3: 58°C for 1 minute; stage 4: 72°C for 1 minute; 32 cycles; stage 5 : 72°C for 5min; store at 16°C.
进一步地,所述步骤S2中分枝杆菌特异引物1扩增的序列为761bp,分枝杆菌特异引物2扩增的序列为219bp,分枝杆菌特异引物3扩增的序列为531bp,分枝杆菌特异引物4扩增的序列为1031bp,分枝杆菌特异引物5扩增的序列为666bp,分枝杆菌特异引物6扩增的序列为991bp,分枝杆菌特异引物7扩增的序列为392bp。Further, in the step S2, the sequence amplified by the mycobacterium-specific primer 1 is 761bp, the sequence amplified by the mycobacterium-specific primer 2 is 219bp, and the sequence amplified by the mycobacterium-specific primer 3 is 531bp. The sequence amplified by the specific primer 4 is 1031bp, the sequence amplified by the mycobacterium-specific primer 5 is 666bp, the sequence amplified by the mycobacterium-specific primer 6 is 991bp, and the sequence amplified by the mycobacterium-specific primer 7 is 392bp.
其中,所述引物对1扩增序列为761bp,具体序列如下:Wherein, the amplified sequence of the primer pair 1 is 761bp, and the specific sequence is as follows:
ggcaaggtcaccccgaagggtgagaccgagctgacgccggaggagcggctgctgcgtgccatcttcggtgagaaggcccgcgaggtgcgcgacacttcgctgaaggtgccgcacggcgaatccggcaaggtgatcggcattcgggtgttttcccgcgaggacgaggacgagttgccggccggtgtcaacgagctggtgcgtgtgtatgtggctcagaaacgcaagatctccgacggtgacaagctggccggccggcacggcaacaagggcgtgatcggcaagatcctgccggttgaggacatgccgttccttgccgacggcaccccggtggacattattttgaacacccacggcgtgccgcgacggatgaacatcggccagattttggagacccacctgggttggtgtgcccacagcggctggaaggtcgacgccgccaagggggttccggactgggccgccaggctgcccgacgaactgctcgaggcgcagccgaacgccattgtgtcgacgccggtgttcgacggcgcccaggaggccgagctgcagggcctgttgtcgtgcacgctgcccaaccgcgacggtgacgtgctggtcgacgccgacggcaaggccatgctcttcgacgggcgcagcggcgagccgttcccgtacccggtcacggttggctacatgtacatcatgaagctgcaccacctggtggacgacaagatccacgcccgctccaccgggccgtactcgatgatcacccagcagccgct;ggcaaggtcaccccgaagggtgagaccgagctgacgccggaggagcggctgctgcgtgccatcttcggtgagaaggcccgcgaggtgcgcgacacttcgctgaaggtgccgcacggcgaatccggcaaggtgatcggcattcgggtgttttcccgcgaggacgaggacgagttgccggccggtgtcaacgagctggtgcgtgtgtatgtggctcagaaacgcaagatctccgacggtgacaagctggccggccggcacggcaacaagggcgtgatcggcaagatcctgccggttgaggacatgccgttccttgccgacggcaccccggtggacattattttgaacacccacggcgtgccgcgacggatgaacatcggccagattttggagacccacctgggttggtgtgcccacagcggctggaaggtcgacgccgccaagggggttccggactgggccgccaggctgcccgacgaactgctcgaggcgcagccgaacgccattgtgtcgacgccggtgttcgacggcgcccaggaggccgagctgcagggcctgttgtcgtgcacgctgcccaaccgcgacggtgacgtgctggtcgacgccgacggcaaggccatgctcttcgacgggcgcagcggcgagccgttcccgtacccggtcacggttggctacatgtacatcatgaagctgcaccacctggtggacgacaagatccacgcccgctccaccgggccgtactcgatgatcacccagcagccgct;
所述引物对2扩增序列为219bp,具体序列如下:The amplified sequence of the primer pair 2 is 219bp, and the specific sequence is as follows:
cgctcatcgctgcgttcgcggtagcccgccccgcacagggcgtcggcttcagcccccatcaaggcggcgatgaacgtcgagagcagcccgcgcagcagatccgggctcgcctgtgcgagttggtcagccagaagctgctcggtgtcgataagatgagaagaggtcattgcgtcatttccttcgattgacttttgctggtcgtttcgaaggatcacgcga;cgctcatcgctgcgttcgcggtagcccgccccgcacagggcgtcggcttcagcccccatcaaggcggcgatgaacgtcgagagcagcccgcgcagcagatccgggctcgcctgtgcgagttggtcagccagaagctgctcggtgtcgataagatgagaagaggtcattgcgtcatttccttcgattgacttttgctggtcgtttcgaaggatcacgcga;
所述引物对3扩增序列为531bp,具体序列如下:The amplified sequence of the primer pair 3 is 531bp, and the specific sequence is as follows:
gacctgacgccgctgacactgccgacgcccgcgcagttggcgttacgtcgatcggtgatccgacgtgccggcgcagtgattgacgcgaaccggtcctggcgtcggttgatgtcgttggcgcggtaggcgttccccgatgtgtggaccgcgttcgccgggtcgttaccgaccgcgacagcggtgctggggcgttggcccgacatccgcttgctggccggcgcaccgacccgccacgttgaccgccgtcatcgccgcgcacacccgcggtgtcgccgacaccccggcccggccgaggccatcaagaccgccgcaaccggctgggccgcgttctgggacgggcacctcgacctggacgcactggccgtcgatgtcaccgagcatctcagcgacctcaccgacgaccgatgcgcgcgttggtgatgccggtgaccaagaaggtgttgatcttgggtgactagtcaatggtggtggccagggtgagcagttcggggatctgcgagtcgatgcgccaggcaggaagcggtgtaggtg;gacctgacgccgctgacactgccgacgcccgcgcagttggcgttacgtcgatcggtgatccgacgtgccggcgcagtgattgacgcgaaccggtcctggcgtcggttgatgtcgttggcgcggtaggcgttccccgatgtgtggaccgcgttcgccgggtcgttaccgaccgcgacagcggtgctggggcgttggcccgacatccgcttgctggccggcgcaccgacccgccacgttgaccgccgtcatcgccgcgcacacccgcggtgtcgccgacaccccggcccggccgaggccatcaagaccgccgcaaccggctgggccgcgttctgggacgggcacctcgacctggacgcactggccgtcgatgtcaccgagcatctcagcgacctcaccgacgaccgatgcgcgcgttggtgatgccggtgaccaagaaggtgttgatcttgggtgactagtcaatggtggtggccagggtgagcagttcggggatctgcgagtcgatgcgccaggcaggaagcggtgtaggtg;
所述引物对4扩增序列为1031bp,具体序列如下:The amplified sequence of the primer pair 4 is 1031bp, and the specific sequence is as follows:
gacatgtacgagagacggcatgagcgcggaatgtgcgaccgtgccgtcgagatgaccgacgtcggcgctacggcagcccccaccggacctatcgcgcggggcagcgtcgctcgggtcggcgcggcgaccgcgttggccgttgcctgcgtctacacggtcatctatctggcggcccgcgacctacccccggcttgtttttcgatattcgcggtgttttggggggcgctcggcattgccaccggcgccacccacggcctcctgcaagaaacgacccgcgaggtccgctgggtgcgctccacccaaatagttgcgggccatcgtacccatccgctgcgggtggccgggatgattggcaccgtcgcggccgtcgtaattgcgggtagctcaccgctgtggagccgacagctattcgtcgaggggcgctggctgtccgtggggctactcagcgttggggtggccgggttctgcgcgcaggcgaccctgctgggcgcgctggccggcgtcgaccggtggacacagtacgggtcactgatggtgaccgacgcggtcatccggttggcggtcgccgcggcagcggttgtgatcggatggggtctggccgggtacttgtgggccgccaccgcgggagcggtggcgtggctgctcatgctgatggcctcgcccaccgcgcgcagcgcggccagcctgctgacgcccgggggaatcgccacgttcgtgcgcggtgccgctcattcgataaccgccgcgggtgccagcgcgattctggtaatgggtttcccagtgttgctcaaagtgacctccgaccagttaggggcaaagggcggagcggtcatcctggctgtgaccttgacgcgtgcgccgcttctggtcccactgagcgcgatgcaaggcaacctgatcgcgcatttcgtcgaccggcgcacccaacggcttcgggcgctgatcgcaccggcgctggtcgtcggcggcatcggtgcggtcgggatgttggccgcagggcttaccggtccctggttgctgcgtgttggatt;gacatgtacgagagacggcatgagcgcggaatgtgcgaccgtgccgtcgagatgaccgacgtcggcgctacggcagcccccaccggacctatcgcgcggggcagcgtcgctcgggtcggcgcggcgaccgcgttggccgttgcctgcgtctacacggtcatctatctggcggcccgcgacctacccccggcttgtttttcgatattcgcggtgttttggggggcgctcggcattgccaccggcgccacccacggcctcctgcaagaaacgacccgcgaggtccgctgggtgcgctccacccaaatagttgcgggccatcgtacccatccgctgcgggtggccgggatgattggcaccgtcgcggccgtcgtaattgcgggtagctcaccgctgtggagccgacagctattcgtcgaggggcgctggctgtccgtggggctactcagcgttggggtggccgggttctgcgcgcaggcgaccctgctgggcgcgctggccggcgtcgaccggtggacacagtacgggtcactgatggtgaccgacgcggtcatccggttggcggtcgccgcggcagcggttgtgatcggatggggtctggccgggtacttgtgggccgccaccgcgggagcggtggcgtggctgctcatgctgatggcctcgcccaccgcgcgcagcgcggccagcctgctgacgcccgggggaatcgccacgttcgtgcgcggtgccgctcattcgataaccgccgcgggtgccagcgcgattctggtaatgggtttcccagtgttgctcaaagtgacctccgaccagttaggggcaaagggcggagcggtcatcctggctgtgaccttgacgcgtgcgccgcttctggtcccactgagcgcgatgcaaggcaacctgatcgcgcatttcgtcgaccggcgcacccaacggcttcgggcgctgatcgcaccggcgctggtcgtcggcggcatcggtgcggtcgggatgttggccgcagggc ttaccggtccctggttgctgcgtgttggatt;
所述引物对5扩增序列为666bp,具体序列如下:The amplified sequence of the primer pair 5 is 666bp, and the specific sequence is as follows:
agggattcggcgttcgggattcctgaagtcaagcggggtctggttgccggcggcgggggattgctgcggttgccggagcgcatcccgtatgcgatagccatggagttggcgctgaccggtgacaacctaccggccgaacgcgcgcacgagctggggctcgtcaacgttttggccgagccggggaccgccctcgatgctgcgatcgcgttggcggagaagatcaccgccaatgggccgctggcggtggtggccaccaagcggattatcaccgagtcgcgtgggtggagtcccgacactatgttcgctgagcagatgaagatcctggtgccggtgttcacctccaacgacgcgaaggaaggtgcgatcgcgttcgccgagaggcgccggccccgttggacgggcacctagcccagctacgcgacggtgtagcccatcggcagcaggacactcttttgctgggtgaagtgttcgacaccctcgggcccgttctcgcggccgattccggagttcttgtagccgccgaagggtgagccgggatcgaaggcgtaccagttgattccgtatgtcccggtgcggatctgctgcgagatcttgatgcctttgggcacgtcggtggtccacacgctgcccgccagcccatacactgaatcgttggcgatcgcgatc;agggattcggcgttcgggattcctgaagtcaagcggggtctggttgccggcggcgggggattgctgcggttgccggagcgcatcccgtatgcgatagccatggagttggcgctgaccggtgacaacctaccggccgaacgcgcgcacgagctggggctcgtcaacgttttggccgagccggggaccgccctcgatgctgcgatcgcgttggcggagaagatcaccgccaatgggccgctggcggtggtggccaccaagcggattatcaccgagtcgcgtgggtggagtcccgacactatgttcgctgagcagatgaagatcctggtgccggtgttcacctccaacgacgcgaaggaaggtgcgatcgcgttcgccgagaggcgccggccccgttggacgggcacctagcccagctacgcgacggtgtagcccatcggcagcaggacactcttttgctgggtgaagtgttcgacaccctcgggcccgttctcgcggccgattccggagttcttgtagccgccgaagggtgagccgggatcgaaggcgtaccagttgattccgtatgtcccggtgcggatctgctgcgagatcttgatgcctttgggcacgtcggtggtccacacgctgcccgccagcccatacactgaatcgttggcgatcgcgatc;
所述引物对6扩增序列为991bp,具体序列如下:The amplified sequence of the primer pair 6 is 991bp, and the specific sequence is as follows:
gggtctgacggccaaactcatcatctggtacccgcactatgcctggctgttgttgagcgtctacctcacggtagccctggttgcgctcgtggtggtcgggtcgatggctcacgtccggcgcgtttcaccggtcgtaaaacgaactctggaattgatcgacggcgccatgatcgctgccatcattcccatgctgctgtggatcaccggggtgtacgacacggtccgcaatatccggttctgagccggatcggctgattggcggttcctgacagaacatcgaggacacggcgcaggtttgcataccttcggcgcccgacaaattgctgcgattgagcgtgtggcgcgtccggtaaaatttgctcgatggggaacacgtataggagatccggcaatggctgaaccgttggccgtcgatcccaccggcttgagcgcagcggccgcgaaattggccggcctcgtttttccgcagcctccggcgccgatcgcggtcagcggaacggattcggtggtagcagcaatcaacgagaccatgccaagcatcgaatcgctggtcagtgacgggctgcccggcgtgaaagccgccctgactcgaacagcatccaacatgaacgcggcggcggacgtctatgcgaagaccgatcagtcactgggaaccagtttgagccagtatgcattcggctcgtcgggcgaaggcctggctggcgtcgcctcggtcggtggtcagccaagtcaggctacccagctgctgagcacacccgtgtcacaggtcacgacccagctcggcgagacggccgctgagctggcaccccgtgttgttgcgacggtgccgcaactcgttcagctggctccgcacgccgttcagatgtcgcaaaacgcatcccccatcgctcagacgatcagtcaaaccgcccaacaggccgcccagagcgcgcagggcggcagcggcccaatgcccgcacagcttgccagcgctgaaaaaccggccaccgag;gggtctgacggccaaactcatcatctggtacccgcactatgcctggctgttgttgagcgtctacctcacggtagccctggttgcgctcgtggtggtcgggtcgatggctcacgtccggcgcgtttcaccggtcgtaaaacgaactctggaattgatcgacggcgccatgatcgctgccatcattcccatgctgctgtggatcaccggggtgtacgacacggtccgcaatatccggttctgagccggatcggctgattggcggttcctgacagaacatcgaggacacggcgcaggtttgcataccttcggcgcccgacaaattgctgcgattgagcgtgtggcgcgtccggtaaaatttgctcgatggggaacacgtataggagatccggcaatggctgaaccgttggccgtcgatcccaccggcttgagcgcagcggccgcgaaattggccggcctcgtttttccgcagcctccggcgccgatcgcggtcagcggaacggattcggtggtagcagcaatcaacgagaccatgccaagcatcgaatcgctggtcagtgacgggctgcccggcgtgaaagccgccctgactcgaacagcatccaacatgaacgcggcggcggacgtctatgcgaagaccgatcagtcactgggaaccagtttgagccagtatgcattcggctcgtcgggcgaaggcctggctggcgtcgcctcggtcggtggtcagccaagtcaggctacccagctgctgagcacacccgtgtcacaggtcacgacccagctcggcgagacggccgctgagctggcaccccgtgttgttgcgacggtgccgcaactcgttcagctggctccgcacgccgttcagatgtcgcaaaacgcatcccccatcgctcagacgatcagtcaaaccgcccaacaggccgcccagagcgcgcagggcggcagcggcccaatgcccgcacagcttgccagcgctgaaaaaccggccaccgag;
所述引物对7扩增序列为392bp,具体序列如下:The amplified sequence of the primer pair 7 is 392bp, and the specific sequence is as follows:
cgatagaccatgagtccgtctccatcggccctgctcgccgaccacccggaccgcattcgttggaacgcgaaatacgagtgcgctgaccccacggaggcggtatttgcgcccatatcctggctcggcgacgtgctgcagttcggggtgccagaagggccggttctggaactggcgtgcggtcggtccggcaccgcgctggggctagccgcggcgggccgctgcgtgactgcgatcgacgtttccgataccgcgttggttcagctcgagctcgaagcgacccgacgggaattggccgatcgcctcacactggtgcacgccgatctctgctcctggcagtcgggggatggacgctttgctctggtactttgccgactattctggcatccgcccac。cgatagaccatgagtccgtctccatcggccctgctcgccgaccacccggaccgcattcgttggaacgcgaaatacgagtgcgctgaccccacggaggcggtatttgcgcccatatcctggctcggcgacgtgctgcagttcggggtgccagaagggccggttctggaactggcgtgcggtcggtccggcaccgcgctggggctagccgcggcgggccgctgcgtgactgcgatcgacgtttccgataccgcgttggttcagctcgagctcgaagcgacccgacgggaattggccgatcgcctcacactggtgcacgccgatctctgctcctggcagtcgggggatggacgctttgctctggtactttgccgactattctggcatccgcccac。
进一步地,所述分枝杆菌为结核分枝杆菌或非洲分枝杆菌II型、肯尼迪分枝杆菌、非洲分枝杆菌I型、山羊分枝杆菌、牛型分枝杆菌、卡介苗、田鼠分枝杆菌和非结核分枝杆菌。Further, the mycobacterium is Mycobacterium tuberculosis or Mycobacterium africanum type II, Mycobacterium Kennedy, Mycobacterium africanum type I, Mycobacterium capricum, Mycobacterium bovis, BCG, Mycobacterium microti and nontuberculous mycobacteria.
除此之外,本发明还提供了所述的用于分枝杆菌快速检测与分型的引物在制备用于检测分枝杆菌试剂盒中的应用。In addition, the present invention also provides the application of the primers for rapid detection and typing of mycobacteria in preparing a kit for detecting mycobacteria.
本发明提供的用于分枝杆菌快速检测与分型的方法:是利用不同类型的分枝杆菌菌株含有不同的特异基因,或相同的基因,而这些相同的基因其片段在不同菌种间的变异性,设计出针对不同类型菌株的7对特异性引物。将这7对特异性引物分别对待测菌株进行PCR扩增,对各引物得到的对应的PCR扩增产物的有无及大小进行检测,并最终判定待测标本的菌种类别。The method for rapid detection and typing of mycobacteria provided by the present invention: utilize different types of mycobacterium strains to contain different specific genes, or the same gene, and the fragments of these same genes are different among different bacterial species Variability, designed 7 pairs of specific primers for different types of strains. The 7 pairs of specific primers were used to perform PCR amplification on the strain to be tested respectively, and the presence or absence and size of the corresponding PCR amplification products obtained by each primer were detected, and finally the strain type of the sample to be tested was determined.
本发明提供的用于分枝杆菌快速检测与分型方法的结果判定方法是:对PCR产物的琼脂糖凝胶电泳结果进行分析:The method for determining the result of the mycobacterium rapid detection and typing method provided by the present invention is: analyze the agarose gel electrophoresis result of the PCR product:
A)若标本中7对引物为阳性扩增结果,且引物1的PCR扩增产物出现大小为761bp的片段,引物2的PCR扩增产物出现大小为219bp的片段,引物3的PCR扩增产物出现大小为531bp的片段,引物4的PCR扩增产物出现大小为1031bp的片段,引物5的PCR扩增产物出现大小为666bp的片段,引物6的PCR扩增产物出现大小为991bp的片段,引物7的PCR扩增产物出现大小为392bp的片段,则说明检出了结核分枝杆菌复合群中的结核分枝杆菌(M.Tuberculosis)或非洲分枝杆菌II型(M.africanum subtype II);A) If the 7 pairs of primers in the sample are positive amplification results, and the PCR amplification product of primer 1 has a fragment size of 761bp, the PCR amplification product of primer 2 has a fragment size of 219bp, and the PCR amplification product of primer 3 has a fragment size of 219bp. A fragment with a size of 531bp appeared, the PCR amplification product of primer 4 appeared a fragment with a size of 1031bp, the PCR amplification product of primer 5 appeared a fragment with a size of 666bp, and the PCR amplification product of primer 6 appeared a fragment with a size of 991bp. If the PCR amplification product of 7 shows a fragment with a size of 392bp, it indicates that Mycobacterium tuberculosis (M.Tuberculosis) or African mycobacterium type II (M.africanum subtype II) in the Mycobacterium tuberculosis complex has been detected;
B)若标本中7对引物PCR扩增产物结果为:引物1-6为阳性扩增结果,且引物1的PCR扩增产物出现大小为761bp的片段,引物2的PCR扩增产物出现大小219bp的片段,引物3的PCR扩增产物出现大小为531bp的片段,引物4的PCR扩增产物出现大小为1031bp的片段,引物5的PCR扩增产物出现大小为666bp的片段,引物6的PCR扩增产物出现大小为991bp的片段;而引物7的PCR扩增产物不含有大小为392bp的片段,则说明检出了结核分枝杆菌复合群中的肯尼迪分枝杆菌(M.Canettii);B) If the results of PCR amplification products of 7 pairs of primers in the specimen are: primers 1-6 are positive amplification results, and the PCR amplification product of primer 1 has a fragment size of 761bp, and the PCR amplification product of primer 2 has a size of 219bp The PCR amplification product of primer 3 has a fragment of 531bp in size, the PCR amplification product of primer 4 has a fragment of 1031bp in size, the PCR amplification product of primer 5 has a fragment of 666bp in size, and the PCR amplification product of primer 6 has a fragment of 666bp in size. The amplification product has a fragment size of 991bp; and the PCR amplification product of primer 7 does not contain a fragment size of 392bp, indicating that the Mycobacterium Kennedy (M.Canettii) in the Mycobacterium tuberculosis complex has been detected;
C)若标本中7对PCR扩增产物结果为:引物1-4和引物6、7为阳性扩增结果,且引物1的PCR扩增产物出现大小为761bp的片段,引物2的PCR扩增产物出现大小为219bp的片段,引物3的PCR扩增产物出现大小为531bp的片段,引物4的PCR扩增产物出现大小为1031bp的片段,引物6的PCR扩增产物出现大小为991bp的片段,引物7的PCR扩增产物出现大小为392bp的片段;而引物5的PCR扩增产物不含有大小为666bp的片段,则说明检出了结核分枝杆菌复合群中的非洲分枝杆菌I型(M.africanum subtype I);C) If the results of 7 pairs of PCR amplification products in the sample are: primers 1-4 and primers 6 and 7 are positive amplification results, and the PCR amplification product of primer 1 has a fragment size of 761bp, the PCR amplification of primer 2 The product has a fragment size of 219bp, the PCR amplification product of primer 3 has a fragment size of 531bp, the PCR amplification product of primer 4 has a fragment size of 1031bp, and the PCR amplification product of primer 6 has a fragment size of 991bp, The PCR amplification product of primer 7 has a fragment of 392bp in size; and the PCR amplification product of primer 5 does not contain a fragment of 666bp in size, which indicates that Mycobacterium africa type I in the Mycobacterium tuberculosis complex ( M. africanum subtype I);
D)若标本中的7对PCR扩增产物结果为:引物1-4和引物6为阳性扩增结果,且引物1的PCR扩增产物出现大小为761bp的片段,引物2的PCR扩增产物出现大小为219bp的片段,引物3的PCR扩增产物出现大小为531bp的片段,引物4的PCR扩增产物出现大小为1031bp的片段,引物6的PCR扩增产物出现大小为991bp的片段;而引物5的PCR扩增产物不含有大小为666bp的片段,引物7的PCR扩增产物不含有大小为392bp的片段,则说明检出了结核分枝杆菌复合群中的山羊分枝杆菌(M.Caprae);D) If the results of 7 pairs of PCR amplification products in the specimen are: primers 1-4 and primer 6 are positive amplification results, and the PCR amplification product of primer 1 has a fragment size of 761bp, the PCR amplification product of primer 2 A fragment with a size of 219bp appeared, the PCR amplification product of primer 3 had a fragment of 531bp in size, the PCR amplification product of primer 4 had a fragment of 1031bp in size, and the PCR amplification product of primer 6 had a fragment of 991bp in size; and The PCR amplification product of primer 5 does not contain a fragment with a size of 666bp, and the PCR amplification product of primer 7 does not contain a fragment with a size of 392bp, indicating that Mycobacterium capricatus (M. Caprae);
E)若标本中的7对PCR扩增产物结果为:引物1-3和引物6为阳性扩增结果,且引物1的PCR扩增产物出现大小为761bp的片段,引物2的PCR扩增产物出现大小为219bp的片段,引物3的PCR扩增产物出现大小为531bp的片段,引物6的PCR扩增产物出现大小为991bp的片段;而引物4的PCR扩增产物不含有大小为1031bp的片段,引物5的PCR扩增产物不含有大小为666bp的片段,引物7的PCR扩增产物不含有大小为392bp的片段,则说明检出了结核分枝杆菌复合群中的牛型分枝杆菌(M.Bovis);E) If the results of 7 pairs of PCR amplification products in the specimen are: primers 1-3 and primer 6 are positive amplification results, and the PCR amplification product of primer 1 has a fragment size of 761bp, the PCR amplification product of primer 2 A fragment with a size of 219bp appeared, the PCR amplification product of primer 3 had a fragment with a size of 531bp, and the PCR amplification product with primer 6 had a fragment with a size of 991bp; while the PCR amplification product of primer 4 did not contain a fragment with a size of 1031bp , the PCR amplification product of primer 5 does not contain the fragment that size is 666bp, and the PCR amplification product of primer 7 does not contain the fragment that size is 392bp, then explanation has detected the Mycobacterium bovis in the Mycobacterium tuberculosis complex ( M. Bovis);
F)若标本中的7对PCR扩增产物结果为:引物1-3为阳性扩增结果,且引物1的PCR扩增产物出现大小为761bp的片段,引物2的PCR扩增产物出现大小为219bp的片段,引物3的PCR扩增产物出现大小为531bp的片段;而引物4的PCR扩增产物不含有大小为1031bp的片段,引物5的PCR扩增产物不含有大小为666bp的片段,引物6的PCR扩增产物不含有大小为991bp的片段,引物7的PCR扩增产物不含有大小为392bp的片段,则说明检出了结核分枝杆菌复合群中的卡介苗(M.bovis BCG);F) If the results of 7 pairs of PCR amplification products in the specimen are: primers 1-3 are positive amplification results, and the PCR amplification product of primer 1 has a fragment size of 761bp, and the PCR amplification product of primer 2 has a size of For a fragment of 219bp, the PCR amplification product of primer 3 showed a fragment of 531bp in size; while the PCR amplification product of primer 4 did not contain a fragment of 1031bp in size, and the PCR amplification product of primer 5 did not contain a fragment of 666bp in size. The PCR amplification product of 6 does not contain a fragment with a size of 991bp, and the PCR amplification product of primer 7 does not contain a fragment with a size of 392bp, which means that BCG (M.bovis BCG) in the Mycobacterium tuberculosis complex has been detected;
G)若标本中的7对PCR扩增产物结果为:引物1、引物2、引物4、引物6和引物7为阳性扩增结果,即引物1的PCR扩增产物出现大小为761bp的片段,引物2的PCR扩增产物出现大小为219bp的片段,引物4的PCR扩增产物出现大小为1031bp的片段,引物6的PCR扩增产物出现大小为991bp的片段,引物7的PCR扩增产物出现大小为392bp的片段;而引物3的PCR扩增产物不含有大小为531bp的片段,引物5的PCR扩增产物不含有大小为666bp的片段,则说明检出了结核分枝杆菌复合群中的田鼠分枝杆菌(M.Microti);G) If the results of 7 pairs of PCR amplification products in the specimen are: primer 1, primer 2, primer 4, primer 6 and primer 7 are positive amplification results, that is, the PCR amplification product of primer 1 has a fragment size of 761bp, The PCR amplification product of primer 2 has a fragment size of 219bp, the PCR amplification product of primer 4 has a fragment size of 1031bp, the PCR amplification product of primer 6 has a fragment size of 991bp, and the PCR amplification product of primer 7 has a A fragment with a size of 392bp; and the PCR amplification product of primer 3 does not contain a fragment with a size of 531bp, and the PCR amplification product of primer 5 does not contain a fragment with a size of 666bp, indicating that the Mycobacterium tuberculosis complex has been detected Mycobacterium microti (M. Microti);
H)若标本中的7对PCR扩增产物结果为:仅引物1为阳性扩增结果,且引物1的PCR扩增产物出现大小为761bp的片段;而引物2的PCR扩增产物不含有大小为219bp的片段,引物3的PCR扩增产物不含有大小为531bp的片段,引物4的PCR扩增产物不含有大小为1031bp的片段,引物5的PCR扩增产物不含有大小为666bp的片段,引物6的PCR扩增产物不含有大小为991bp的片段,引物7的PCR扩增产物不含有大小为392bp的片段,则说明检出了非结核分枝杆菌(M.Fortuitum)。H) If the results of 7 pairs of PCR amplification products in the specimen are: only primer 1 is a positive amplification result, and the PCR amplification product of primer 1 has a fragment size of 761bp; while the PCR amplification product of primer 2 does not contain a fragment of size The PCR amplification product of primer 3 does not contain a fragment of 531bp in size, the PCR amplification product of primer 4 does not contain a fragment of 1031bp in size, and the PCR amplification product of primer 5 does not contain a fragment of 666bp in size. The PCR amplified product of primer 6 does not contain a fragment with a size of 991 bp, and the PCR amplified product of primer 7 does not contain a fragment with a size of 392 bp, indicating that non-tuberculous mycobacteria (M.Fortuitum) have been detected.
本发明提供的用于分枝杆菌快速检测与分型的引物不仅可以区分结核分枝杆菌和非结核分枝杆菌,还可以进一步的区分结核分枝杆菌复合群中的各成员菌。将本发明提供的7对引物采用相同的扩增反应条件,可一次性完成7个不同引物对的PCR反应,观察凝胶电泳结果即可快速鉴别结核与非结核分枝杆菌,以及结核分枝杆菌复合群各成员菌,具有操作简便快捷、特异性好和准确度高的优点,可以有效的辅助结核病的临床诊断、指导临床开展早期有效的化疗。The primers provided by the invention for rapid detection and typing of mycobacteria can not only distinguish tuberculosis mycobacteria and non-tuberculosis mycobacteria, but also can further distinguish each member bacteria in the tuberculosis mycobacterium complex. Using the 7 pairs of primers provided by the present invention under the same amplification reaction conditions, the PCR reactions of 7 different primer pairs can be completed at one time, and the results of gel electrophoresis can be used to quickly identify tuberculosis and non-tuberculous mycobacteria, as well as tuberculosis mycobacteria The members of the Bacillus complex have the advantages of simple and quick operation, good specificity and high accuracy, and can effectively assist the clinical diagnosis of tuberculosis and guide the clinical development of early and effective chemotherapy.
与现有技术相比,本发明的有益效果是:本发明提供的用于分枝杆菌快速检测与分型的引物,可以区分结核分枝杆菌和非结核分枝杆菌,同时还可以进一步的区分结核分枝杆菌复合群中的各成员菌,具有特异性好和准确性高的优点,极大的提高了检测效率。此外,本发明还提供了用于分枝杆菌快速检测与分型的方法,通过使用本发明提供的特异性的引物,操作简便快捷、特异性好,可以有效的辅助结核病的临床诊断、指导临床开展早期有效的化疗,是一种理想的分枝杆菌快速检测与分型的方法。Compared with the prior art, the beneficial effects of the present invention are: the primers provided by the present invention for the rapid detection and typing of mycobacteria can distinguish tuberculosis mycobacteria and non-tuberculous mycobacteria, and can further distinguish Each member of the Mycobacterium tuberculosis complex has the advantages of good specificity and high accuracy, which greatly improves the detection efficiency. In addition, the present invention also provides a method for rapid detection and typing of mycobacteria. By using the specific primers provided by the present invention, the operation is simple and fast, and the specificity is good, which can effectively assist the clinical diagnosis of tuberculosis and guide clinical Carrying out early and effective chemotherapy is an ideal method for rapid detection and typing of mycobacteria.
附图说明Description of drawings
图1为引物对1-7对结核分枝杆菌(M.Tuberculosis)或非洲分枝杆菌II型(M.africanumsubtype II)扩增结果图;Fig. 1 is a graph showing the amplification results of primer pairs 1-7 to Mycobacterium tuberculosis (M.Tuberculosis) or African mycobacterium type II (M.africanum subtype II);
图2为引物对1-7对肯尼迪分枝杆菌(M.Canettii)扩增结果图;Fig. 2 is the amplification result figure of primer pair 1-7 to Mycobacterium Kennedy (M.Canettii);
图3为引物对1-7对非洲分枝杆菌I型(M.africanum subtype I)扩增结果图;Fig. 3 is a graph showing the amplification results of primer pairs 1-7 to African mycobacterium type I (M.africanum subtype I);
图4为引物对1-7对山羊分枝杆菌(M.Caprae)扩增结果图;Fig. 4 is the amplification result figure of primer pair 1-7 to Mycobacterium capricatus (M.Caprae);
图5为引物对1-7对牛型分枝杆菌(M.Bovis)扩增结果图;Fig. 5 is the amplification result figure of primer pair 1-7 to Mycobacterium bovis (M.Bovis);
图6为引物对1-7对卡介苗(M.bovis BCG)扩增结果图;Figure 6 is a diagram showing the amplification results of primer pairs 1-7 to BCG (M.bovis BCG);
图7为引物对1-7对田鼠分枝杆菌(M.Microti)扩增结果图;Fig. 7 is a graph showing the amplification results of primer pairs 1-7 to Mycobacterium microti (M.Microti);
图8为引物对1-7对非结核分枝杆菌(M.Fortuitum)的扩增结果图。Fig. 8 is a diagram showing the amplification results of primer pairs 1-7 for non-tuberculous mycobacteria (M.Fortuitum).
具体实施方式detailed description
以上内容是结合具体的优选实施方式对本发明所作的进一步详细说明,不能认定本发明的具体实施只局限于这些说明。对于本发明所属技术领域的普通技术人员来说,在不脱离本发明构思的前提下,还可以做出若干简单推演或替换,都应当视为属于本发明的保护范围。其中,Chelex 100 resin购买自bio-rad公司(货号:1432832)。The above content is a further detailed description of the present invention in conjunction with specific preferred embodiments, and it cannot be assumed that the specific implementation of the present invention is limited to these descriptions. For those of ordinary skill in the technical field of the present invention, without departing from the concept of the present invention, some simple deduction or replacement can be made, which should be regarded as belonging to the protection scope of the present invention. Among them, Chelex 100 resin was purchased from bio-rad company (article number: 1432832).
实施例1、引物Embodiment 1, primer
本发明提供一种用于分枝杆菌快速检测与分型的引物。The invention provides a primer for rapid detection and typing of mycobacteria.
表1本发明提供的引物Table 1 Primers provided by the present invention
实施例2、引物的配对及其扩增片段大小Embodiment 2, the pairing of primer and its amplified fragment size
本发明提供的分枝杆菌特异引物1扩增的序列为761bp,分枝杆菌特异引物2扩增的序列为219bp,分枝杆菌特异引物3扩增的序列为531bp,分枝杆菌特异引物4扩增的序列为1031bp,分枝杆菌特异引物5扩增的序列为666bp,分枝杆菌特异引物6扩增的序列为991bp,分枝杆菌特异引物7扩增的序列为392bp。The sequence amplified by mycobacterium-specific primer 1 provided by the invention is 761bp, the sequence amplified by mycobacterium-specific primer 2 is 219bp, the sequence amplified by mycobacterium-specific primer 3 is 531bp, and the sequence amplified by mycobacterium-specific primer 4 is 531bp. The sequence amplified by the mycobacterium-specific primer 5 is 1031bp, the sequence amplified by the mycobacterium-specific primer 5 is 666bp, the sequence amplified by the mycobacterium-specific primer 6 is 991bp, and the sequence amplified by the mycobacterium-specific primer 7 is 392bp.
表2引物的配对及其扩增片段大小Table 2 The pairing of primers and the size of their amplified fragments
其中,所述引物对1扩增序列为761bp,具体序列如下:Wherein, the amplified sequence of the primer pair 1 is 761bp, and the specific sequence is as follows:
ggcaaggtcaccccgaagggtgagaccgagctgacgccggaggagcggctgctgcgtgccatcttcggtgagaaggcccgcgaggtgcgcgacacttcgctgaaggtgccgcacggcgaatccggcaaggtgatcggcattcgggtgttttcccgcgaggacgaggacgagttgccggccggtgtcaacgagctggtgcgtgtgtatgtggctcagaaacgcaagatctccgacggtgacaagctggccggccggcacggcaacaagggcgtgatcggcaagatcctgccggttgaggacatgccgttccttgccgacggcaccccggtggacattattttgaacacccacggcgtgccgcgacggatgaacatcggccagattttggagacccacctgggttggtgtgcccacagcggctggaaggtcgacgccgccaagggggttccggactgggccgccaggctgcccgacgaactgctcgaggcgcagccgaacgccattgtgtcgacgccggtgttcgacggcgcccaggaggccgagctgcagggcctgttgtcgtgcacgctgcccaaccgcgacggtgacgtgctggtcgacgccgacggcaaggccatgctcttcgacgggcgcagcggcgagccgttcccgtacccggtcacggttggctacatgtacatcatgaagctgcaccacctggtggacgacaagatccacgcccgctccaccgggccgtactcgatgatcacccagcagccgct;ggcaaggtcaccccgaagggtgagaccgagctgacgccggaggagcggctgctgcgtgccatcttcggtgagaaggcccgcgaggtgcgcgacacttcgctgaaggtgccgcacggcgaatccggcaaggtgatcggcattcgggtgttttcccgcgaggacgaggacgagttgccggccggtgtcaacgagctggtgcgtgtgtatgtggctcagaaacgcaagatctccgacggtgacaagctggccggccggcacggcaacaagggcgtgatcggcaagatcctgccggttgaggacatgccgttccttgccgacggcaccccggtggacattattttgaacacccacggcgtgccgcgacggatgaacatcggccagattttggagacccacctgggttggtgtgcccacagcggctggaaggtcgacgccgccaagggggttccggactgggccgccaggctgcccgacgaactgctcgaggcgcagccgaacgccattgtgtcgacgccggtgttcgacggcgcccaggaggccgagctgcagggcctgttgtcgtgcacgctgcccaaccgcgacggtgacgtgctggtcgacgccgacggcaaggccatgctcttcgacgggcgcagcggcgagccgttcccgtacccggtcacggttggctacatgtacatcatgaagctgcaccacctggtggacgacaagatccacgcccgctccaccgggccgtactcgatgatcacccagcagccgct;
所述引物对2扩增序列为219bp,具体序列如下:The amplified sequence of the primer pair 2 is 219bp, and the specific sequence is as follows:
cgctcatcgctgcgttcgcggtagcccgccccgcacagggcgtcggcttcagcccccatcaaggcggcgatgaacgtcgagagcagcccgcgcagcagatccgggctcgcctgtgcgagttggtcagccagaagctgctcggtgtcgataagatgagaagaggtcattgcgtcatttccttcgattgacttttgctggtcgtttcgaaggatcacgcga;cgctcatcgctgcgttcgcggtagcccgccccgcacagggcgtcggcttcagcccccatcaaggcggcgatgaacgtcgagagcagcccgcgcagcagatccgggctcgcctgtgcgagttggtcagccagaagctgctcggtgtcgataagatgagaagaggtcattgcgtcatttccttcgattgacttttgctggtcgtttcgaaggatcacgcga;
所述引物对3扩增序列为531bp,具体序列如下:The amplified sequence of the primer pair 3 is 531bp, and the specific sequence is as follows:
gacctgacgccgctgacactgccgacgcccgcgcagttggcgttacgtcgatcggtgatccgacgtgccggcgcagtgattgacgcgaaccggtcctggcgtcggttgatgtcgttggcgcggtaggcgttccccgatgtgtggaccgcgttcgccgggtcgttaccgaccgcgacagcggtgctggggcgttggcccgacatccgcttgctggccggcgcaccgacccgccacgttgaccgccgtcatcgccgcgcacacccgcggtgtcgccgacaccccggcccggccgaggccatcaagaccgccgcaaccggctgggccgcgttctgggacgggcacctcgacctggacgcactggccgtcgatgtcaccgagcatctcagcgacctcaccgacgaccgatgcgcgcgttggtgatgccggtgaccaagaaggtgttgatcttgggtgactagtcaatggtggtggccagggtgagcagttcggggatctgcgagtcgatgcgccaggcaggaagcggtgtaggtg;gacctgacgccgctgacactgccgacgcccgcgcagttggcgttacgtcgatcggtgatccgacgtgccggcgcagtgattgacgcgaaccggtcctggcgtcggttgatgtcgttggcgcggtaggcgttccccgatgtgtggaccgcgttcgccgggtcgttaccgaccgcgacagcggtgctggggcgttggcccgacatccgcttgctggccggcgcaccgacccgccacgttgaccgccgtcatcgccgcgcacacccgcggtgtcgccgacaccccggcccggccgaggccatcaagaccgccgcaaccggctgggccgcgttctgggacgggcacctcgacctggacgcactggccgtcgatgtcaccgagcatctcagcgacctcaccgacgaccgatgcgcgcgttggtgatgccggtgaccaagaaggtgttgatcttgggtgactagtcaatggtggtggccagggtgagcagttcggggatctgcgagtcgatgcgccaggcaggaagcggtgtaggtg;
所述引物对4扩增序列为1031bp,具体序列如下:The amplified sequence of the primer pair 4 is 1031bp, and the specific sequence is as follows:
gacatgtacgagagacggcatgagcgcggaatgtgcgaccgtgccgtcgagatgaccgacgtcggcgctacggcagcccccaccggacctatcgcgcggggcagcgtcgctcgggtcggcgcggcgaccgcgttggccgttgcctgcgtctacacggtcatctatctggcggcccgcgacctacccccggcttgtttttcgatattcgcggtgttttggggggcgctcggcattgccaccggcgccacccacggcctcctgcaagaaacgacccgcgaggtccgctgggtgcgctccacccaaatagttgcgggccatcgtacccatccgctgcgggtggccgggatgattggcaccgtcgcggccgtcgtaattgcgggtagctcaccgctgtggagccgacagctattcgtcgaggggcgctggctgtccgtggggctactcagcgttggggtggccgggttctgcgcgcaggcgaccctgctgggcgcgctggccggcgtcgaccggtggacacagtacgggtcactgatggtgaccgacgcggtcatccggttggcggtcgccgcggcagcggttgtgatcggatggggtctggccgggtacttgtgggccgccaccgcgggagcggtggcgtggctgctcatgctgatggcctcgcccaccgcgcgcagcgcggccagcctgctgacgcccgggggaatcgccacgttcgtgcgcggtgccgctcattcgataaccgccgcgggtgccagcgcgattctggtaatgggtttcccagtgttgctcaaagtgacctccgaccagttaggggcaaagggcggagcggtcatcctggctgtgaccttgacgcgtgcgccgcttctggtcccactgagcgcgatgcaaggcaacctgatcgcgcatttcgtcgaccggcgcacccaacggcttcgggcgctgatcgcaccggcgctggtcgtcggcggcatcggtgcggtcgggatgttggccgcagggcttaccggtccctggttgctgcgtgttggatt;gacatgtacgagagacggcatgagcgcggaatgtgcgaccgtgccgtcgagatgaccgacgtcggcgctacggcagcccccaccggacctatcgcgcggggcagcgtcgctcgggtcggcgcggcgaccgcgttggccgttgcctgcgtctacacggtcatctatctggcggcccgcgacctacccccggcttgtttttcgatattcgcggtgttttggggggcgctcggcattgccaccggcgccacccacggcctcctgcaagaaacgacccgcgaggtccgctgggtgcgctccacccaaatagttgcgggccatcgtacccatccgctgcgggtggccgggatgattggcaccgtcgcggccgtcgtaattgcgggtagctcaccgctgtggagccgacagctattcgtcgaggggcgctggctgtccgtggggctactcagcgttggggtggccgggttctgcgcgcaggcgaccctgctgggcgcgctggccggcgtcgaccggtggacacagtacgggtcactgatggtgaccgacgcggtcatccggttggcggtcgccgcggcagcggttgtgatcggatggggtctggccgggtacttgtgggccgccaccgcgggagcggtggcgtggctgctcatgctgatggcctcgcccaccgcgcgcagcgcggccagcctgctgacgcccgggggaatcgccacgttcgtgcgcggtgccgctcattcgataaccgccgcgggtgccagcgcgattctggtaatgggtttcccagtgttgctcaaagtgacctccgaccagttaggggcaaagggcggagcggtcatcctggctgtgaccttgacgcgtgcgccgcttctggtcccactgagcgcgatgcaaggcaacctgatcgcgcatttcgtcgaccggcgcacccaacggcttcgggcgctgatcgcaccggcgctggtcgtcggcggcatcggtgcggtcgggatgttggccgcagggc ttaccggtccctggttgctgcgtgttggatt;
所述引物对5扩增序列为666bp,具体序列如下:The amplified sequence of the primer pair 5 is 666bp, and the specific sequence is as follows:
agggattcggcgttcgggattcctgaagtcaagcggggtctggttgccggcggcgggggattgctgcggttgccggagcgcatcccgtatgcgatagccatggagttggcgctgaccggtgacaacctaccggccgaacgcgcgcacgagctggggctcgtcaacgttttggccgagccggggaccgccctcgatgctgcgatcgcgttggcggagaagatcaccgccaatgggccgctggcggtggtggccaccaagcggattatcaccgagtcgcgtgggtggagtcccgacactatgttcgctgagcagatgaagatcctggtgccggtgttcacctccaacgacgcgaaggaaggtgcgatcgcgttcgccgagaggcgccggccccgttggacgggcacctagcccagctacgcgacggtgtagcccatcggcagcaggacactcttttgctgggtgaagtgttcgacaccctcgggcccgttctcgcggccgattccggagttcttgtagccgccgaagggtgagccgggatcgaaggcgtaccagttgattccgtatgtcccggtgcggatctgctgcgagatcttgatgcctttgggcacgtcggtggtccacacgctgcccgccagcccatacactgaatcgttggcgatcgcgatc;agggattcggcgttcgggattcctgaagtcaagcggggtctggttgccggcggcgggggattgctgcggttgccggagcgcatcccgtatgcgatagccatggagttggcgctgaccggtgacaacctaccggccgaacgcgcgcacgagctggggctcgtcaacgttttggccgagccggggaccgccctcgatgctgcgatcgcgttggcggagaagatcaccgccaatgggccgctggcggtggtggccaccaagcggattatcaccgagtcgcgtgggtggagtcccgacactatgttcgctgagcagatgaagatcctggtgccggtgttcacctccaacgacgcgaaggaaggtgcgatcgcgttcgccgagaggcgccggccccgttggacgggcacctagcccagctacgcgacggtgtagcccatcggcagcaggacactcttttgctgggtgaagtgttcgacaccctcgggcccgttctcgcggccgattccggagttcttgtagccgccgaagggtgagccgggatcgaaggcgtaccagttgattccgtatgtcccggtgcggatctgctgcgagatcttgatgcctttgggcacgtcggtggtccacacgctgcccgccagcccatacactgaatcgttggcgatcgcgatc;
所述引物对6扩增序列为991bp,具体序列如下:The amplified sequence of the primer pair 6 is 991bp, and the specific sequence is as follows:
gggtctgacggccaaactcatcatctggtacccgcactatgcctggctgttgttgagcgtctacctcacggtagccctggttgcgctcgtggtggtcgggtcgatggctcacgtccggcgcgtttcaccggtcgtaaaacgaactctggaattgatcgacggcgccatgatcgctgccatcattcccatgctgctgtggatcaccggggtgtacgacacggtccgcaatatccggttctgagccggatcggctgattggcggttcctgacagaacatcgaggacacggcgcaggtttgcataccttcggcgcccgacaaattgctgcgattgagcgtgtggcgcgtccggtaaaatttgctcgatggggaacacgtataggagatccggcaatggctgaaccgttggccgtcgatcccaccggcttgagcgcagcggccgcgaaattggccggcctcgtttttccgcagcctccggcgccgatcgcggtcagcggaacggattcggtggtagcagcaatcaacgagaccatgccaagcatcgaatcgctggtcagtgacgggctgcccggcgtgaaagccgccctgactcgaacagcatccaacatgaacgcggcggcggacgtctatgcgaagaccgatcagtcactgggaaccagtttgagccagtatgcattcggctcgtcgggcgaaggcctggctggcgtcgcctcggtcggtggtcagccaagtcaggctacccagctgctgagcacacccgtgtcacaggtcacgacccagctcggcgagacggccgctgagctggcaccccgtgttgttgcgacggtgccgcaactcgttcagctggctccgcacgccgttcagatgtcgcaaaacgcatcccccatcgctcagacgatcagtcaaaccgcccaacaggccgcccagagcgcgcagggcggcagcggcccaatgcccgcacagcttgccagcgctgaaaaaccggccaccgag;gggtctgacggccaaactcatcatctggtacccgcactatgcctggctgttgttgagcgtctacctcacggtagccctggttgcgctcgtggtggtcgggtcgatggctcacgtccggcgcgtttcaccggtcgtaaaacgaactctggaattgatcgacggcgccatgatcgctgccatcattcccatgctgctgtggatcaccggggtgtacgacacggtccgcaatatccggttctgagccggatcggctgattggcggttcctgacagaacatcgaggacacggcgcaggtttgcataccttcggcgcccgacaaattgctgcgattgagcgtgtggcgcgtccggtaaaatttgctcgatggggaacacgtataggagatccggcaatggctgaaccgttggccgtcgatcccaccggcttgagcgcagcggccgcgaaattggccggcctcgtttttccgcagcctccggcgccgatcgcggtcagcggaacggattcggtggtagcagcaatcaacgagaccatgccaagcatcgaatcgctggtcagtgacgggctgcccggcgtgaaagccgccctgactcgaacagcatccaacatgaacgcggcggcggacgtctatgcgaagaccgatcagtcactgggaaccagtttgagccagtatgcattcggctcgtcgggcgaaggcctggctggcgtcgcctcggtcggtggtcagccaagtcaggctacccagctgctgagcacacccgtgtcacaggtcacgacccagctcggcgagacggccgctgagctggcaccccgtgttgttgcgacggtgccgcaactcgttcagctggctccgcacgccgttcagatgtcgcaaaacgcatcccccatcgctcagacgatcagtcaaaccgcccaacaggccgcccagagcgcgcagggcggcagcggcccaatgcccgcacagcttgccagcgctgaaaaaccggccaccgag;
所述引物对7扩增序列为392bp,具体序列如下:The amplified sequence of the primer pair 7 is 392bp, and the specific sequence is as follows:
cgatagaccatgagtccgtctccatcggccctgctcgccgaccacccggaccgcattcgttggaacgcgaaatacgagtgcgctgaccccacggaggcggtatttgcgcccatatcctggctcggcgacgtgctgcagttcggggtgccagaagggccggttctggaactggcgtgcggtcggtccggcaccgcgctggggctagccgcggcgggccgctgcgtgactgcgatcgacgtttccgataccgcgttggttcagctcgagctcgaagcgacccgacgggaattggccgatcgcctcacactggtgcacgccgatctctgctcctggcagtcgggggatggacgctttgctctggtactttgccgactattctggcatccgcccac。cgatagaccatgagtccgtctccatcggccctgctcgccgaccacccggaccgcattcgttggaacgcgaaatacgagtgcgctgaccccacggaggcggtatttgcgcccatatcctggctcggcgacgtgctgcagttcggggtgccagaagggccggttctggaactggcgtgcggtcggtccggcaccgcgctggggctagccgcggcgggccgctgcgtgactgcgatcgacgtttccgataccgcgttggttcagctcgagctcgaagcgacccgacgggaattggccgatcgcctcacactggtgcacgccgatctctgctcctggcagtcgggggatggacgctttgctctggtactttgccgactattctggcatccgcccac。
实施例3、一种用于分枝杆菌快速检测与分型的方法Embodiment 3, a kind of method for rapid detection and typing of mycobacteria
1)应用细菌基因组DNA提取液提取待测标本中的细菌基因组DNA:选取标本进行预处理,再使用细菌基因组DNA提取液提取细菌基因组DNA,其中,所述DNA提取液的成分如表3所示:1) Apply the bacterial genomic DNA extraction solution to extract the bacterial genomic DNA in the specimen to be tested: select the specimen for pretreatment, and then use the bacterial genomic DNA extraction solution to extract the bacterial genomic DNA, wherein the composition of the DNA extraction solution is shown in Table 3 :
表3 DNA提取液的成分Table 3 Components of DNA extraction solution
2)以提取待测标本中的细菌基因组DNA为模板,采用实施例1中表1所述的7对引物分别进行PCR扩增,所述的PCR反应混合液组分如表4所示:2) taking the bacterial genome DNA in the sample to be extracted as a template, adopting 7 pairs of primers described in Table 1 in Example 1 to carry out PCR amplification respectively, and the components of the PCR reaction mixture are as shown in Table 4:
表4 PCR反应混合液组分Table 4 PCR reaction mixture components
其反应条件为:阶段1:95℃5min;阶段2:95℃1min;阶段3:58℃1min;阶段4:72℃1min;32个循环;阶段5:72℃5min;在16℃贮存。The reaction conditions are: stage 1: 95°C for 5 min; stage 2: 95°C for 1 min; stage 3: 58°C for 1 min; stage 4: 72°C for 1 min; 32 cycles; stage 5: 72°C for 5 min; storage at 16°C.
3)将所得的PCR产物进行琼脂糖凝胶电泳。3) The obtained PCR product is subjected to agarose gel electrophoresis.
4)凝胶成像结果如表5所示。4) The gel imaging results are shown in Table 5.
表5 PCR琼脂糖凝胶电泳图谱Table 5 PCR agarose gel electrophoresis patterns
A)若标本中7对引物为阳性扩增结果,且引物1的PCR扩增产物出现大小为761bp的片段,引物2的PCR扩增产物出现大小为219bp的片段,引物3的PCR扩增产物出现大小为531bp的片段,引物4的PCR扩增产物出现大小为1031bp的片段,引物5的PCR扩增产物出现大小为666bp的片段,引物6的PCR扩增产物出现大小为991bp的片段,引物7的PCR扩增产物出现大小为392bp的片段,则说明检出了结核分枝杆菌复合群中的结核分枝杆菌(M.Tuberculosis)或非洲分枝杆菌II型(M.africanum subtype II),试验结果如图1所示;A) If the 7 pairs of primers in the sample are positive amplification results, and the PCR amplification product of primer 1 has a fragment size of 761bp, the PCR amplification product of primer 2 has a fragment size of 219bp, and the PCR amplification product of primer 3 has a fragment size of 219bp. A fragment with a size of 531bp appeared, the PCR amplification product of primer 4 appeared a fragment with a size of 1031bp, the PCR amplification product of primer 5 appeared a fragment with a size of 666bp, and the PCR amplification product of primer 6 appeared a fragment with a size of 991bp. If the PCR amplification product of 7 has a fragment with a size of 392bp, it indicates that Mycobacterium tuberculosis (M.Tuberculosis) or African mycobacterium type II (M.africanum subtype II) in the Mycobacterium tuberculosis complex has been detected, The test results are shown in Figure 1;
B)若标本中7对引物PCR扩增产物结果为:引物1-6为阳性扩增结果,且引物1的PCR扩增产物出现大小为761bp的片段,引物2的PCR扩增产物出现大小219bp的片段,引物3的PCR扩增产物出现大小为531bp的片段,引物4的PCR扩增产物出现大小为1031bp的片段,引物5的PCR扩增产物出现大小为666bp的片段,引物6的PCR扩增产物出现大小为991bp的片段;而引物7的PCR扩增产物不含有大小为392bp的片段,则说明检出了结核分枝杆菌复合群中的肯尼迪分枝杆菌(M.Canettii),试验结果如图2所示;B) If the results of PCR amplification products of 7 pairs of primers in the specimen are: primers 1-6 are positive amplification results, and the PCR amplification product of primer 1 has a fragment size of 761bp, and the PCR amplification product of primer 2 has a size of 219bp The PCR amplification product of primer 3 has a fragment of 531bp in size, the PCR amplification product of primer 4 has a fragment of 1031bp in size, the PCR amplification product of primer 5 has a fragment of 666bp in size, and the PCR amplification product of primer 6 has a fragment of 666bp in size. The amplification product has a fragment size of 991bp; and the PCR amplification product of primer 7 does not contain a fragment size of 392bp, which indicates that Mycobacterium Kennedy (M.Canettii) in the Mycobacterium tuberculosis complex has been detected. as shown in picture 2;
C)若标本中7对PCR扩增产物结果为:引物1-4和引物6、7为阳性扩增结果,且引物1的PCR扩增产物出现大小为761bp的片段,引物2的PCR扩增产物出现大小为219bp的片段,引物3的PCR扩增产物出现大小为531bp的片段,引物4的PCR扩增产物出现大小为1031bp的片段,引物6的PCR扩增产物出现大小为991bp的片段,引物7的PCR扩增产物出现大小为392bp的片段;而引物5的PCR扩增产物不含有大小为666bp的片段,则说明检出了结核分枝杆菌复合群中的非洲分枝杆菌I型(M.africanum subtype I),试验结果如图3所示;C) If the results of 7 pairs of PCR amplification products in the sample are: primers 1-4 and primers 6 and 7 are positive amplification results, and the PCR amplification product of primer 1 has a fragment size of 761bp, the PCR amplification of primer 2 The product has a fragment size of 219bp, the PCR amplification product of primer 3 has a fragment size of 531bp, the PCR amplification product of primer 4 has a fragment size of 1031bp, and the PCR amplification product of primer 6 has a fragment size of 991bp, The PCR amplification product of primer 7 has a fragment of 392bp in size; and the PCR amplification product of primer 5 does not contain a fragment of 666bp in size, which indicates that Mycobacterium africa type I in the Mycobacterium tuberculosis complex ( M.africanum subtype I), the test results are as shown in Figure 3;
D)若标本中的7对PCR扩增产物结果为:引物1-4和引物6为阳性扩增结果,且引物1的PCR扩增产物出现大小为761bp的片段,引物2的PCR扩增产物出现大小为219bp的片段,引物3的PCR扩增产物出现大小为531bp的片段,引物4的PCR扩增产物出现大小为1031bp的片段,引物6的PCR扩增产物出现大小为991bp的片段;而引物5的PCR扩增产物不含有大小为666bp的片段,引物7的PCR扩增产物不含有大小为392bp的片段,则说明检出了结核分枝杆菌复合群中的山羊分枝杆菌(M.Caprae),试验结果如图4所示;D) If the results of 7 pairs of PCR amplification products in the specimen are: primers 1-4 and primer 6 are positive amplification results, and the PCR amplification product of primer 1 has a fragment size of 761bp, the PCR amplification product of primer 2 A fragment with a size of 219bp appeared, the PCR amplification product of primer 3 had a fragment of 531bp in size, the PCR amplification product of primer 4 had a fragment of 1031bp in size, and the PCR amplification product of primer 6 had a fragment of 991bp in size; and The PCR amplification product of primer 5 does not contain a fragment with a size of 666bp, and the PCR amplification product of primer 7 does not contain a fragment with a size of 392bp, indicating that Mycobacterium capricatus (M. Caprae), test result as shown in Figure 4;
E)若标本中的7对PCR扩增产物结果为:引物1-3和引物6为阳性扩增结果,且引物1的PCR扩增产物出现大小为761bp的片段,引物2的PCR扩增产物出现大小为219bp的片段,引物3的PCR扩增产物出现大小为531bp的片段,引物6的PCR扩增产物出现大小为991bp的片段;而引物4的PCR扩增产物不含有大小为1031bp的片段,引物5的PCR扩增产物不含有大小为666bp的片段,引物7的PCR扩增产物不含有大小为392bp的片段,则说明检出了结核分枝杆菌复合群中的牛型分枝杆菌(M.Bovis),试验结果如图5所示;E) If the results of 7 pairs of PCR amplification products in the specimen are: primers 1-3 and primer 6 are positive amplification results, and the PCR amplification product of primer 1 has a fragment size of 761bp, the PCR amplification product of primer 2 A fragment with a size of 219bp appeared, the PCR amplification product of primer 3 had a fragment with a size of 531bp, and the PCR amplification product with primer 6 had a fragment with a size of 991bp; while the PCR amplification product of primer 4 did not contain a fragment with a size of 1031bp , the PCR amplification product of primer 5 does not contain the fragment that size is 666bp, and the PCR amplification product of primer 7 does not contain the fragment that size is 392bp, then explanation has detected the Mycobacterium bovis in the Mycobacterium tuberculosis complex ( M.Bovis), the test results are shown in Figure 5;
F)若标本中的7对PCR扩增产物结果为:引物1-3为阳性扩增结果,且引物1的PCR扩增产物出现大小为761bp的片段,引物2的PCR扩增产物出现大小为219bp的片段,引物3的PCR扩增产物出现大小为531bp的片段;而引物4的PCR扩增产物不含有大小为1031bp的片段,引物5的PCR扩增产物不含有大小为666bp的片段,引物6的PCR扩增产物不含有大小为991bp的片段,引物7的PCR扩增产物不含有大小为392bp的片段,则说明检出了结核分枝杆菌复合群中的卡介苗(M.bovis BCG),试验结果如图6所示;F) If the results of 7 pairs of PCR amplification products in the specimen are: primers 1-3 are positive amplification results, and the PCR amplification product of primer 1 has a fragment size of 761bp, and the PCR amplification product of primer 2 has a size of For a fragment of 219bp, the PCR amplification product of primer 3 showed a fragment of 531bp in size; while the PCR amplification product of primer 4 did not contain a fragment of 1031bp in size, and the PCR amplification product of primer 5 did not contain a fragment of 666bp in size. The PCR amplification product of 6 does not contain the fragment that is 991bp in size, and the PCR amplification product of primer 7 does not contain the fragment that is 392bp in size, which means that BCG (M.bovis BCG) in the Mycobacterium tuberculosis complex has been detected, The test results are shown in Figure 6;
G)若标本中的7对PCR扩增产物结果为:引物1、引物2、引物4、引物6和引物7为阳性扩增结果,即引物1的PCR扩增产物出现大小为761bp的片段,引物2的PCR扩增产物出现大小为219bp的片段,引物4的PCR扩增产物出现大小为1031bp的片段,引物6的PCR扩增产物出现大小为991bp的片段,引物7的PCR扩增产物出现大小为392bp的片段;而引物3的PCR扩增产物不含有大小为531bp的片段,引物5的PCR扩增产物不含有大小为666bp的片段,则说明检出了结核分枝杆菌复合群中的田鼠分枝杆菌(M.Microti),试验结果如图7所示;G) If the results of 7 pairs of PCR amplification products in the specimen are: primer 1, primer 2, primer 4, primer 6 and primer 7 are positive amplification results, that is, the PCR amplification product of primer 1 has a fragment size of 761bp, The PCR amplification product of primer 2 has a fragment size of 219bp, the PCR amplification product of primer 4 has a fragment size of 1031bp, the PCR amplification product of primer 6 has a fragment size of 991bp, and the PCR amplification product of primer 7 has a A fragment with a size of 392bp; and the PCR amplification product of primer 3 does not contain a fragment with a size of 531bp, and the PCR amplification product of primer 5 does not contain a fragment with a size of 666bp, indicating that the Mycobacterium tuberculosis complex has been detected Mycobacterium microti (M.Microti), the test results are shown in Figure 7;
H)若标本中的7对PCR扩增产物结果为:仅引物1为阳性扩增结果,且引物1的PCR扩增产物出现大小为761bp的片段;而引物2的PCR扩增产物不含有大小为219bp的片段,引物3的PCR扩增产物不含有大小为531bp的片段,引物4的PCR扩增产物不含有大小为1031bp的片段,引物5的PCR扩增产物不含有大小为666bp的片段,引物6的PCR扩增产物不含有大小为991bp的片段,引物7的PCR扩增产物不含有大小为392bp的片段,则说明检出了非结核分枝杆菌(M.Fortuitum),试验结果如图8所示。H) If the results of 7 pairs of PCR amplification products in the specimen are: only primer 1 is a positive amplification result, and the PCR amplification product of primer 1 has a fragment size of 761bp; while the PCR amplification product of primer 2 does not contain a fragment of size The PCR amplification product of primer 3 does not contain a fragment of 531bp in size, the PCR amplification product of primer 4 does not contain a fragment of 1031bp in size, and the PCR amplification product of primer 5 does not contain a fragment of 666bp in size. The PCR amplification product of primer 6 does not contain a fragment with a size of 991bp, and the PCR amplification product of primer 7 does not contain a fragment with a size of 392bp, which means that non-tuberculous mycobacteria (M.Fortuitum) has been detected, and the test results are shown in the figure 8.
与现有技术相比,本发明的有益效果是:本发明提供的用于分枝杆菌快速检测与分型的引物,可以区分结核分枝杆菌和非结核分枝杆菌,同时还可以进一步的区分结核分枝杆菌复合群中的各成员菌,具有特异性好和准确性高的优点,极大的提高了检测效率。此外,本发明还提供了用于分枝杆菌快速检测与分型的方法,通过使用本发明提供的特异性的引物,操作简便快捷、特异性好,可以有效的辅助结核病的临床诊断、指导临床开展早期有效的化疗,是一种理想的分枝杆菌快速检测与分型的方法。Compared with the prior art, the beneficial effects of the present invention are: the primers provided by the present invention for the rapid detection and typing of mycobacteria can distinguish tuberculosis mycobacteria and non-tuberculous mycobacteria, and can further distinguish Each member of the Mycobacterium tuberculosis complex has the advantages of good specificity and high accuracy, which greatly improves the detection efficiency. In addition, the present invention also provides a method for rapid detection and typing of mycobacteria. By using the specific primers provided by the present invention, the operation is simple and fast, and the specificity is good, which can effectively assist the clinical diagnosis of tuberculosis and guide clinical Carrying out early and effective chemotherapy is an ideal method for rapid detection and typing of mycobacteria.
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610292154.1A CN105907861A (en) | 2016-05-05 | 2016-05-05 | Method and primer for quick detection and classification of mycobacteria |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610292154.1A CN105907861A (en) | 2016-05-05 | 2016-05-05 | Method and primer for quick detection and classification of mycobacteria |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105907861A true CN105907861A (en) | 2016-08-31 |
Family
ID=56752328
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610292154.1A Pending CN105907861A (en) | 2016-05-05 | 2016-05-05 | Method and primer for quick detection and classification of mycobacteria |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105907861A (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107099601A (en) * | 2017-05-27 | 2017-08-29 | 中国人民解放军白求恩国际和平医院 | RT LAMP detect Primer composition, corresponding kit and the detection method of viable bacteria of Mycobacterium tuberculosis through |
CN107815491A (en) * | 2017-11-21 | 2018-03-20 | 弗罗朗(北京)生物科技有限公司 | A kind of kit and its application method of quick single-minded detection Mycobacterium tuberculosis |
CN110079621A (en) * | 2019-04-29 | 2019-08-02 | 湖南圣湘生物科技有限公司 | Oligonucleotide combinatorial, method and kit for mycobacteria strain identification |
CN112501321A (en) * | 2020-11-19 | 2021-03-16 | 厦门大学 | Molecular typing method of mycobacterium tuberculosis |
CN112501324A (en) * | 2020-11-26 | 2021-03-16 | 广州迪澳生物科技有限公司 | Primer and kit for detecting mycobacterium tuberculosis complex and nontuberculous mycobacterium complex based on loop-mediated isothermal amplification |
CN114990238A (en) * | 2022-03-09 | 2022-09-02 | 中国动物卫生与流行病学中心 | Method for detecting bovine tuberculosis pathogen with high sensitivity |
CN117737272A (en) * | 2023-12-29 | 2024-03-22 | 深圳吉因加医学检验实验室 | Screening method for target microorganism markers and application of screening method |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1491285A (en) * | 2000-12-26 | 2004-04-21 | �����﹤����ʽ���� | Method of detecting pathogenic microorganism |
CN1715422A (en) * | 2004-06-30 | 2006-01-04 | 中国农业科学院哈尔滨兽医研究所 | Novel Mycobacterium bovis and the method for quick identification of mycobacterium tuberculosis and application |
CN102533959A (en) * | 2010-12-30 | 2012-07-04 | 华中农业大学 | Multiplex polymerase chain reaction (PCR) kit for identifying mycobacterium tuberculosis |
CN102947465A (en) * | 2009-12-21 | 2013-02-27 | 贝克顿·迪金森公司 | Methods for identifying drug resistant mycobacterium |
CN104651520A (en) * | 2015-03-05 | 2015-05-27 | 首都医科大学附属北京胸科医院 | Primer for identifying mycobacterium tuberculosis complex strains and application of primer |
CN104862406A (en) * | 2015-06-01 | 2015-08-26 | 山东省农业科学院奶牛研究中心 | Primer and probe for on-site rapid detection of mycobacterium tuberculosis complex and kit thereof |
-
2016
- 2016-05-05 CN CN201610292154.1A patent/CN105907861A/en active Pending
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1491285A (en) * | 2000-12-26 | 2004-04-21 | �����﹤����ʽ���� | Method of detecting pathogenic microorganism |
CN1715422A (en) * | 2004-06-30 | 2006-01-04 | 中国农业科学院哈尔滨兽医研究所 | Novel Mycobacterium bovis and the method for quick identification of mycobacterium tuberculosis and application |
CN102947465A (en) * | 2009-12-21 | 2013-02-27 | 贝克顿·迪金森公司 | Methods for identifying drug resistant mycobacterium |
CN102533959A (en) * | 2010-12-30 | 2012-07-04 | 华中农业大学 | Multiplex polymerase chain reaction (PCR) kit for identifying mycobacterium tuberculosis |
CN104651520A (en) * | 2015-03-05 | 2015-05-27 | 首都医科大学附属北京胸科医院 | Primer for identifying mycobacterium tuberculosis complex strains and application of primer |
CN104862406A (en) * | 2015-06-01 | 2015-08-26 | 山东省农业科学院奶牛研究中心 | Primer and probe for on-site rapid detection of mycobacterium tuberculosis complex and kit thereof |
Non-Patent Citations (6)
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107099601A (en) * | 2017-05-27 | 2017-08-29 | 中国人民解放军白求恩国际和平医院 | RT LAMP detect Primer composition, corresponding kit and the detection method of viable bacteria of Mycobacterium tuberculosis through |
CN107815491A (en) * | 2017-11-21 | 2018-03-20 | 弗罗朗(北京)生物科技有限公司 | A kind of kit and its application method of quick single-minded detection Mycobacterium tuberculosis |
CN107815491B (en) * | 2017-11-21 | 2020-12-29 | 弗罗朗(北京)生物科技有限公司 | Kit for rapidly and specifically detecting mycobacterium tuberculosis and use method thereof |
CN110079621A (en) * | 2019-04-29 | 2019-08-02 | 湖南圣湘生物科技有限公司 | Oligonucleotide combinatorial, method and kit for mycobacteria strain identification |
CN112501321A (en) * | 2020-11-19 | 2021-03-16 | 厦门大学 | Molecular typing method of mycobacterium tuberculosis |
CN112501324A (en) * | 2020-11-26 | 2021-03-16 | 广州迪澳生物科技有限公司 | Primer and kit for detecting mycobacterium tuberculosis complex and nontuberculous mycobacterium complex based on loop-mediated isothermal amplification |
CN114990238A (en) * | 2022-03-09 | 2022-09-02 | 中国动物卫生与流行病学中心 | Method for detecting bovine tuberculosis pathogen with high sensitivity |
CN117737272A (en) * | 2023-12-29 | 2024-03-22 | 深圳吉因加医学检验实验室 | Screening method for target microorganism markers and application of screening method |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105907861A (en) | Method and primer for quick detection and classification of mycobacteria | |
Mugnier et al. | Worldwide dissemination of the blaOXA-23 Carbapenemase gene of Acinetobacter baumannii1 | |
Zhang et al. | Mycobacterium tuberculosis complex CRISPR genotyping: improving efficiency, throughput and discriminative power of ‘spoligotyping’with new spacers and a microbead-based hybridization assay | |
Nucera et al. | Comparison of API 20E and invA PCR for identification of Salmonella enterica isolates from swine production units | |
Takahashi et al. | Novel technique of quantitative nested real-time PCR assay for Mycobacterium tuberculosis DNA | |
CN104059977B (en) | A kind of Salmonella serogroup authentication method and test kit thereof | |
CN104946730B (en) | PCR-specific primers for identifying deer antler and their detection methods | |
CN102533959A (en) | Multiplex polymerase chain reaction (PCR) kit for identifying mycobacterium tuberculosis | |
CN103361434A (en) | Multiple fluorescence PCR detection kit and detection method for clostridium difficile toxin genes | |
CN104087654A (en) | Multiple PCR identification kit of salmonella and five serotypes of salmonella | |
CN109680084A (en) | A kind of primed probe and method for the compound group of Fluorescence quantitative PCR detection mycobacterium tuberculosis | |
Payne et al. | High-resolution melt PCR analysis for genotyping of Ureaplasma parvum isolates directly from clinical samples | |
CN116064864A (en) | Primer combination and kit for detecting drug-resistant genes of mycobacterium tuberculosis | |
Ichikawa et al. | Characterization of Mycobacterium avium clinical isolates in Japan using subspecies-specific insertion sequences, and identification of a new insertion sequence, IS Mav6 | |
Sharma et al. | Evaluation of polymerase chain reaction using protein b primers for rapid diagnosis of tuberculous meningitis | |
CN111334592A (en) | Nucleic acid composition for detecting helicobacter pylori drug-resistant gene and kit and application thereof | |
CN105695560A (en) | Method for identifying Bifidobacterium lactis in infant formula milk powder | |
CN105219847B (en) | A kind of Legionella quick detection and parting kit and its detection method | |
CN105154538B (en) | The primer and method of a kind of Legionella quick detection and parting | |
Li et al. | Identification and differentiation of clinically relevant mycobacterium species directly from acid-fast bacillus-positive culture broth | |
Horii et al. | Use of a dual priming oligonucleotide system to detect multiple sexually transmitted pathogens in clinical specimens | |
CN104450879B (en) | Sequence, technical platform and method for detecting clostridium difficile ribotyping 027 | |
CN112501321B (en) | Method for molecular typing of mycobacterium tuberculosis | |
CN108060244A (en) | A kind of nucleotide sequence and application for mycobacterium tuberculosis complex detection | |
Vielemeyer et al. | Identification of Bordetella pertussis in a critically ill human immunodeficiency virus-infected patient by direct genotypical analysis of Gram-stained material and discrimination from B. holmesii by using a unique recA gene restriction enzyme site |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20160831 |